Paul C. Boutros, PhD, MBA, discusses the utility of genetic testing in prostate cancer.
Paul C. Boutros, PhD, MBA
Advertisement
Articles by Paul C. Boutros, PhD, MBA
Paul C. Boutros, PhD, MBA, discusses processes that predict disease lethality in men with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Boutros on Processes That Predict Lethality in Prostate CancerPublished: October 26th 2020 | Updated:
Dr. Boutros on the Utility of Genetic Testing in Prostate CancerPublished: November 24th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5